An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,464 | -17,111 | -10,649 | -51,321 | -43,799 |
| Depreciation Amortization | -953 | -742 | -443 | -3,279 | -2,712 |
| Accounts payable and accrued liabilities | -1,091 | -1,204 | -244 | 641 | -965 |
| Other Working Capital | -1,419 | -4,341 | -1,157 | -3,121 | -4,641 |
| Other Operating Activity | 5,329 | 5,175 | 1,869 | 7,823 | 8,133 |
| Operating Cash Flow | $-24,598 | $-18,223 | $-10,624 | $-49,257 | $-43,984 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -37,863 | -33,973 | -22,307 | -46,751 | -22,371 |
| Sale Of Investment | 59,000 | 49,000 | 31,500 | 101,340 | 83,840 |
| Investing Cash Flow | $21,137 | $15,027 | $9,193 | $54,589 | $61,469 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 113 | 38 | 65 | 372 | 372 |
| Common Stock Repurchased | N/A | 27 | N/A | N/A | N/A |
| Financing Cash Flow | $113 | $65 | $65 | $372 | $372 |
| Beginning Cash Position | 21,351 | 21,351 | 21,351 | 15,647 | 15,647 |
| End Cash Position | 18,003 | 18,220 | 19,985 | 21,351 | 33,504 |
| Net Cash Flow | $-3,348 | $-3,131 | $-1,366 | $5,704 | $17,857 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,598 | -18,223 | -10,624 | -49,257 | -43,984 |
| Free Cash Flow | -24,598 | -18,223 | -10,624 | -49,257 | -43,984 |